AG-80308
Dry Eye Disease, ocular inflammation
Phase 1bActive
Key Facts
Indication
Dry Eye Disease, ocular inflammation
Phase
Phase 1b
Status
Active
Company
About Allgenesis Biotherapeutics
Taiwan biotech developing bispecific ocular biologics for DME, dry eye and AMD.
View full company profile